| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/14/2004 | EP0871615B1 Substituted pyridine derivatives, their preparation and their use as modulators of acetylcholine receptors |
| 07/14/2004 | EP0749442B1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 07/14/2004 | EP0604409B1 Oligonucleotide analogs for detecting and modulating rna activity and gene expression |
| 07/14/2004 | CN1513000A Anti-osteopontin antibody and use thereof |
| 07/14/2004 | CN1512999A 2-{[N-(2-amino-3-(heteroaryl or aryl) propionyl)-aminoacyl]-amino}- alkylboronic acid derivatives |
| 07/14/2004 | CN1512992A Novel adenine derivatives |
| 07/14/2004 | CN1512991A 吡咯烷双环化合物 Pyrrolidine bicyclic compound |
| 07/14/2004 | CN1512988A Pyrimidine, Triazine and pyrazine derivatives as glutamate receptors |
| 07/14/2004 | CN1512987A Novel 1H-indazole compound |
| 07/14/2004 | CN1512985A Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 07/14/2004 | CN1512983A Compounds and compositions as cathepsins inhibitors |
| 07/14/2004 | CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents |
| 07/14/2004 | CN1512892A Orally administering parathyroid hormone and calcitonin |
| 07/14/2004 | CN1512883A Crf受体拮抗剂 Crf receptor antagonist |
| 07/14/2004 | CN1512880A Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | CN1512879A Novel arylaminopropane analogues and their use for treatment of glaucoma |
| 07/14/2004 | CN1512876A Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 07/14/2004 | CN1511947A Gene expression preventing chronic transplanting rejection of recombined gland relative virus mediated haem oxidase-1 (HO-1) |
| 07/14/2004 | CN1511846A Ginkgo protein GAPIIa and its preparing method and use |
| 07/14/2004 | CN1511837A Intermediate for heterocyclic compound in preparing rotamase inhibitor |
| 07/14/2004 | CN1511830A Compound used as antiphlogistic |
| 07/14/2004 | CN1511542A Composition for improving obstacle under pharynx |
| 07/14/2004 | CN1511525A Application of (+) North America coptisine |
| 07/14/2004 | CN1511519A Therapy for immunological disease of type 2 T auxiliary cell mediated |
| 07/14/2004 | CN1157407C Human interleukin-6 inhibitor |
| 07/14/2004 | CN1157392C 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors |
| 07/14/2004 | CN1157390C Indole derivant |
| 07/14/2004 | CN1157387C Process for preparing 11-amino-3-chlorine-6, 11-dihydrogen-5, 5-dioxo-6-methyl-dibenzo [c,f][1,2] thiazine and application of synthetic tianeptine |
| 07/14/2004 | CN1157382C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents cnotaining these compounds |
| 07/14/2004 | CN1157380C Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants agents |
| 07/14/2004 | CN1157379C Tetrahydroquinoline derivatives |
| 07/14/2004 | CN1157371C Monohydrate of cis-4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl] cyclohexancecarboxylate |
| 07/14/2004 | CN1157368C Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR)a |
| 07/14/2004 | CN1157225C Lectin compositions and uses tehreof |
| 07/14/2004 | CN1157224C Novel amide derives. as growth hormone secretagogues |
| 07/14/2004 | CN1157216C Toxic substance removing ointment and its preparing method |
| 07/14/2004 | CN1157188C Method for inhibiting stress-activated protein kinases |
| 07/14/2004 | CN1157186C Cholinergic agents in the treatment of presbyopia |
| 07/14/2004 | CN1157184C Application of liposome preparation in transferring foreign DNA by testis injection |
| 07/13/2004 | US6762320 Monoamine oxidase b inhibitors; alzheimer's disease, senile dementia |
| 07/13/2004 | US6762284 Used for medical applications, including diagnosis and treatment cell growth disorders like restenosis and cancer |
| 07/13/2004 | US6762205 Phenyl sulfamate derivatives |
| 07/13/2004 | US6762200 Phospholipase inhibitors |
| 07/13/2004 | US6762196 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 07/13/2004 | US6762195 Treating diseases mediated by tumor necrosis factor; inhibit angiogenesis and treatment of cancer, inflammatory, and autoimmune diseases |
| 07/13/2004 | US6762194 Quinolinone derivatives |
| 07/13/2004 | US6762192 Useful in therapy and prophylaxis of epilepsy, migraine, and other disorders |
| 07/13/2004 | US6762191 Therapeutic compounds |
| 07/13/2004 | US6762186 Use to treat allergy, nasal congestion, inflammatory and central nervous system-related diseases |
| 07/13/2004 | US6762179 (2-arylamino-4-thiazole)pyrimidine compounds; useful for treating diabetes, alzheimer's disease, stroke, proliferative disorders, and asthma |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/13/2004 | US6762165 Snail venom; muscular disorders, central nervous system disorders, cardiovascular disorders |
| 07/13/2004 | US6762158 Personal care compositions comprising liquid ester mixtures |
| 07/13/2004 | US6762021 Method for diagnosis of crohn's disease |
| 07/13/2004 | US6761910 Sublingually administering a drug with a bioadhesion or mucoadhesion promoting compound; water soluble carrier particles; effective plasma levels within a short time; fentanyl analgesic |
| 07/13/2004 | US6761901 Proliposomal compositions that are advantageously used to deliver biologically active compounds to the gastrointestinal tract after oral administration. |
| 07/13/2004 | US6761889 Adjusting affinity of fab 27/26 fragments/polypeptides generating improved ragweed-induced histamine release inhibition; bronchodilator agents |
| 07/13/2004 | CA2453282A1 Method of modulating the basal metabolic rate of a dieting mammal by administration of a metabolic modulating agent to the dieting mammal |
| 07/13/2004 | CA2375537C Topically applied idebenone-containing agent with protective and regenerative effect |
| 07/13/2004 | CA2313106C Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents |
| 07/13/2004 | CA2301267C Method of enhancing bioavailability of fexofenadine and its derivatives |
| 07/13/2004 | CA2268684C Process for alkylating hindered sulfonamides |
| 07/13/2004 | CA2118859C Enantiomers of 1-[(4-chlorophenyl)-phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine |
| 07/08/2004 | WO2004057330A1 Method of screening cell growth inhibitor and cell growth inhibitor |
| 07/08/2004 | WO2004056992A1 Three-dimensional structure of lipocalin-type prostaglandin d synthase and utilization of the same |
| 07/08/2004 | WO2004056813A1 Benzodiazepine derivative |
| 07/08/2004 | WO2004056755A2 Compounds for the inhibition of non-proteolytic enzymes |
| 07/08/2004 | WO2004056351A1 Pka activity regulator |
| 07/08/2004 | WO2004037184A3 Methods for the treatment of skin disorders |
| 07/08/2004 | WO2004037171A3 Mitotic kinesin inhibitors |
| 07/08/2004 | WO2004035022A3 Prepolymeric materials for site specific delivery to the body |
| 07/08/2004 | WO2004017920A3 Novel biphenyl and biphenyl-like cannabinoids |
| 07/08/2004 | WO2004014301A3 PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE |
| 07/08/2004 | WO2004007498A3 3-phenyl analogs of toxoflavine as kinase inhibitors |
| 07/08/2004 | WO2004006853A3 Treatment and prophylaxis with 4-1bb-binding agents |
| 07/08/2004 | WO2004004641A3 PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPα SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS |
| 07/08/2004 | WO2003105771A3 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/08/2004 | WO2003103663A3 Substituted pyrrolines as kinase inhibitors |
| 07/08/2004 | WO2003097872A3 G - protein coupled receptor marker molecules associated with colorectal lesions |
| 07/08/2004 | WO2003097598A8 Compound exhibiting pgd 2 receptor antagonism |
| 07/08/2004 | WO2003072061A3 Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy |
| 07/08/2004 | WO2003070918A3 Rna interference by modified short interfering nucleic acid |
| 07/08/2004 | WO2003066822A3 Truncated aggrecanase molecules |
| 07/08/2004 | WO2003039553B1 Compositions for treatment of postmenopausal female sexual dysfunction |
| 07/08/2004 | WO2003026591A9 Modification of feeding behavior |
| 07/08/2004 | WO2003024965A3 Heterocyclic compounds that are inhibitors of the enzyme dpp-iv |
| 07/08/2004 | US20040133031 Crystal of bicalutamide and production method thereof |
| 07/08/2004 | US20040132830 Antiproliferative agents; anticancer agents; antiinflammatory agents; autoimmune diseases |
| 07/08/2004 | US20040132822 Crystalline solid form of (2S,5Z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 07/08/2004 | US20040132809 Cell adhesion inhibitors |
| 07/08/2004 | US20040132807 Aurones as telomerase inhibitors |
| 07/08/2004 | US20040132805 preferably also contains a compound that donates, transfers, releases or induces production of nitric oxide and a hydralazine antioxidant; for treating and/or preventing a vascular disease characterized by nitric oxide insufficiency |
| 07/08/2004 | US20040132791 N-(on SO2 ) (2-hydroxy-3-substituted aminopropyl)-substituted; inhibiting retroviral replication |
| 07/08/2004 | US20040132788 thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives; treating neurodegenerative disorders or pain. |
| 07/08/2004 | US20040132781 Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2004 | US20040132768 substituted with (hetero)aryl carbonyloxy group and quaternized, e.g., 3(R)-Diphenylacetoxy-1-(3-phenoxy-propyl)-1-azoniabicyclo[2.2.2]octane; bromide; antimuscarinic agents for treating COPD, chronic bronchitis, asthma and rhinitis. |
| 07/08/2004 | US20040132757 Triazospiro compounds having nociceptin receptor affinity |
| 07/08/2004 | US20040132754 signal transduction inhibitor is a PDGF receptor tyrosine kinase inhibitor or an active ingredient which decreases the activity of the epidermal growth factor; antiproliferative agent |
| 07/08/2004 | US20040132748 Novel adenne derivatives |
| 07/08/2004 | US20040132746 2-substituted 4-pyrrolyl-pyrimidines, e.g., 2-[N-(phenyl)]-4-(2,4-dimethylpyrrol-3-yl)pyrimidineamines in which the phenyl group is 2-, 3-, 4-or 5-substituted by at least one of F, NH2, NO2, OH, Cl, Br, I, CN, CH2OH, CF3 or OMe. |